Known targets — ChEMBL curated mechanism
ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL6909075 | 0.84 | DRD1 (0.35) | DRD1 | |
| Hydrochloric Acid SCHEMBL6910094 | 0.83 | — | — | |
| Hydrochloric Acid SCHEMBL6903988 | 0.82 | DRD1 (0.33) | DRD1 | |
| SCHEMBL6902166 | 0.81 | DRD1 (0.33) | DRD1 | |
| Hydrochloric Acid SCHEMBL6907813 | 0.81 | DRD1 (0.35) | DRD1 | |
| Hydrochloric Acid SCHEMBL6909363 | 0.78 | DRD1 (0.35) | DRD1 | |
| Hydrochloric Acid SCHEMBL6906607 | 0.76 | DRD1 (0.37) | DRD1 | |
| Hydrochloric Acid SCHEMBL6908087 | 0.72 | DRD1 (0.38) | DRD1 | |
| Hydrochloric Acid SCHEMBL6909670 | 0.72 | DRD1 (0.35) | DRD1 | |
| Hydrochloric Acid SCHEMBL6909629 | 0.71 | KDM4E (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6730626-B2 | TRANSITION METAL DERIVATIVE CAN REACT TO FORM AN IONIC COMPLEX WITH THE ALUMINOXANE | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2004-05-04 | — | — | US | disclosed |
| EP-1323723-A1 | TRANSITION METAL COMPOUNDS, POLYMERIZATION CATALYSTS FOR OLEFINS, OLEFIN POLYMERS AND PROCESS FOR THEIR PRODUCTION | IDEMITSU PETROCHEMICAL CO., LTD. (JP) | 2003-07-02 | — | — | EP | disclosed |
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | IDEMITSU KOSAN CO. LTD. (JP) | 2002-12-19 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020193536-A1 | Transition metal compound, polymerization catalysts for olefins, olefin polymers and process for their production | CCNE2, PYM1, AP1M1 | DRD1 197/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.